MedPath

An exploratory randomized controlled study of qianma Zhisou granule in the treatment of cough after infectio

Phase 1
Not yet recruiting
Conditions
Cough after infection
Registration Number
ITMCTR2200006030
Lead Sponsor
The First Affiliated Hospital of Henan University of traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

? It is consistent with the diagnosis of cough after infection by traditional Chinese and Western medicine;
? Course of disease = 3 weeks and < 8 weeks;
? Those aged = 18 and = 60;
? The subjects were informed and voluntarily signed the informed consent form.

Exclusion Criteria

? Allergic to known traditional Chinese medicine ingredients;
? Patients with unstable angina pectoris, acute myocardial infarction, resting pulmonary artery pressure > 45mmhg, cardiac function grade 2 and above;
? Combined with some chronic diseases, such as chronic obstructive pulmonary disease, bronchial asthma, cough variant asthma, reflux esophagitis, chronic pharyngitis, etcIrritable cough;
? Severe liver and kidney disease (severe liver disease refers to liver cirrhosis, portal hypertension and variceal bleeding. Severe kidney disease includes dialysis and kidney transplantation)
? Pregnant or preparing pregnant women, lactating women;
? Those who have participated in clinical trials of other drugs in recent 1 month;
? Patients with purulent sputum or suppurative tonsillitis;
? Patients with dementia and various mental diseases;
? Those who are participating in clinical trials of other interventions.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.